New combo treatment aims to stop Kids' nearsightedness from getting worse

NCT ID NCT06431841

Ongoing Disease control Sponsor: Hospital San Carlos, Madrid Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether combining low-dose atropine eye drops with special glasses (DIMS lenses) can slow the worsening of nearsightedness in children better than atropine alone. About 111 kids aged 4–16 with progressing myopia will be randomly assigned to one of two groups. The main goal is to measure changes in eye prescription and eye length over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: atropine 0.025% eye drops and DIMS spectacle lenses
What this could lead to: If successful, this could show that combining atropine drops with special defocus lenses slows nearsightedness in children better than atropine alone.
What could go wrong: This is a mid-stage trial with only 111 participants, so results may not apply to all children. Atropine can cause light sensitivity or blurry near vision, and the lenses may not be comfortable for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Noemi Guemes

Madrid, Madrid, 28040, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.